ASHTON HUGHES: Open Payments
NPI 1912277229 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 22 payments from 10 companies in 2025. Trend: 2023 $1,200 · 2024 $847 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $221 |
| Novo Nordisk Inc | 5 | $83 |
| PFIZER INC. | 2 | $36 |
| Lilly USA, LLC | 2 | $33 |
| ABBVIE INC. | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
Products named: BREZTRI, Ozempic, Rybelsus, ELIQUIS, MOUNJARO, TRELEGY ELLIPTA, CAPLYTA, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
